Comparison
Companies and funds side by side across all metrics. The best value in each row is highlighted.
Performance from the same starting point
All series start at 100 on the same day. The price is adjusted for dividends.
Green background = the best value in the row (the lowest one for cost metrics).
| Loading… |
Compared securities
- Kymera Therapeutics, Inc. (KYMR): price 125,85 USD, market cap 10,7 mld. USD
- Nurix Therapeutics, Inc. (NRIX): price 14,73 USD, market cap 1,61 mld. USD, P/E 6,1